aTyr Pharma (ATYR)
NASDAQ:ATYR
Holding ATYR?
Track your performance easily

aTyr Pharma (ATYR) Technical Analysis

1,835 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
5Neutral
10Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
aTyr Pharma’s (ATYR) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting aTyr Pharma is a Buy.
aTyr Pharma’s (ATYR) 20-Day exponential moving average is 1.86, while aTyr Pharma’s (ATYR) share price is $1.86, making it a Sell.
aTyr Pharma’s (ATYR) 50-Day exponential moving average is 1.84, while aTyr Pharma’s (ATYR) share price is $1.86, making it a Sell.

aTyr Pharma (ATYR) Pivot Points

Sep 19, 2024, 10:47 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.70
1.77
1.80
1.87
1.90
1.97
2.00
Fibonacci
1.77
1.80
1.83
1.87
1.90
1.93
1.97
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

aTyr Pharma (ATYR) Moving Averages

Sep 19, 2024, 10:47 PM
Period
Simple
Exponential
MA5
1.87Sell
1.86Sell
MA10
1.87Sell
1.86Sell
MA20
1.86Sell
1.86Sell
MA50
1.86Sell
1.84Sell
MA100
1.79Buy
1.80Buy
MA200
1.72Buy
1.69Buy
aTyr Pharma’s (ATYR) 10-Day exponential moving average is 1.86, while aTyr Pharma’s (ATYR) share price is $1.86, making it a Sell.
aTyr Pharma’s (ATYR) 100-Day exponential moving average is 1.80, while aTyr Pharma’s (ATYR) share price is $1.86, making it a Buy.
aTyr Pharma’s (ATYR) stock price is $1.86 and aTyr Pharma’s (ATYR) 50-day simple moving average is 1.86, creating a Sell signal.
aTyr Pharma’s (ATYR) stock price is $1.86 and aTyr Pharma’s (ATYR) 100-day simple moving average is 1.79, creating a Buy signal.
aTyr Pharma’s (ATYR) stock price is $1.86 and aTyr Pharma’s (ATYR) 200-day simple moving average is 1.72, creating a Buy signal.

aTyr Pharma (ATYR) Technical Indicators

Sep 19, 2024, 10:47 PM
Name
Value
Implied Action
RSI (14)
46.29
Neutral
STOCH (9,6)
43.72
Neutral
STOCHRSI (14)
47.09
Neutral
MACD (12,26)
<0.01
Buy
ADX (14)
10.63
Buy
Williams %R
-66.54
Buy
CCI (14)
-43.87
Neutral
ATR (14)
0.11
-
Ultimate Oscillator
31.76
Neutral
ROC
-1.62
Sell
aTyr Pharma’s (ATYR) Relative Strength Index (RSI) is 46.29, creating a Neutral signal.
aTyr Pharma’s (ATYR) Trend Strength Indicator (ADX) is 10.63, creating a Buy signal.
aTyr Pharma’s (ATYR) Commodity Channel Index (CCI) is -43.87, creating a Neutral signal.
aTyr Pharma’s (ATYR) Price Rate of Change (ROC) is -1.62, creating a Sell signal.

FAQ

Is ATYR a Buy, Hold, or Sell?
Based on ATYR’s technical indicators, ATYR is a Sell.
    What is ATYR’s RSI (14)?
    ATYR’s RSI (14) is 46.29, which suggests ATYR is a Neutral.
      What is ATYR’s MACD?
      ATYR’s MACD is <0.01, which suggests ATYR is a Buy.
        What is ATYR’s 5-day moving average?
        ATYR’s 5-day moving average is 1.87, which suggests ATYR is a Sell.
          What is ATYR’s 20-day moving average?
          ATYR 20-day moving average is 1.86, which suggests ATYR is a Sell.
            What is ATYR’s 50-day moving average?
            ATYR’s 50-day moving average is 1.86, which suggests ATYR is a Sell.
              What is ATYR’s 200-day moving average?
              ATYR’s 200-day moving average is 1.72, which suggests ATYR is a Buy.
                What is ATYR’s Williams % R (14)?
                ATYR’s Williams % R (14) is -66.54, which suggests ATYR is a Buy.
                  What is ATYR’s CCI (14)?
                  ATYR’s CCI (14) is -43.87, which suggests ATYR is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis